Low-dose ITI Strategy for Children in Hemophilia A With High-titer Inhibitor and Poor ITI Risk in China

NCT03598725 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Hemophilia A With Inhibitor

Interventions

DRUG: Coagulation Factor VIII
DRUG: Prednisone
DRUG: Rituximab

Sponsor

Beijing Children's Hospital